人間のVMAT2の輸送と阻害メカニズム
Di Wu1,2, Qihao Chen2,3, Zhuoya Yu2,3
1Laboratory of Soft Matter Physics, Institute of Physics, Chinese Academy of Sciences, Beijing, China.
Nature
|December 11, 2023
まとめ
膀性モノアミントランスポーター2 (VMAT2) の構造に関する洞察は,薬によってどのように輸送され抑制されるかを明らかにする. これは神経学的および精神的障害のための新しい治療法を開発するための基盤を提供します.
科学分野:
- 神経科学
- 構造生物学
- 薬理学について
背景:
- 膀性モノアミントランスポーター2 (VMAT2) は,モノアミンの貯蔵と放出に不可欠なモノアミンの神経伝達に不可欠です.
- VMAT2機能障害はパーキンソン病,運動障害,うつ病などの神経学的および精神的疾患に関連しています.
- VMAT2を標的とする薬は,レザーピンとテトラベナジンなど,高血圧とハンチントン病の治療に使用されます.
研究 の 目的:
- VMAT2媒介による輸送と薬物阻害の構造的メカニズムを解明する.
- 基板と阻害剤を併用したヒトVMAT2の高解像度構造データを提供する.
- VMAT2を標的とした合理的な薬剤設計の基礎を築く
主な方法:
- 構造を決定するために,冷凍電子顕微鏡 (cryo-EM) が使用されました.
- 人間のVMAT2はセロトニンと3つの臨床薬 (レスルピン,ケタンセリン,テトラベナジン) と併用して研究されました.
- 構造は高解像度 (3.5−2.8 Å) で解像した.
主要な成果:
- この研究では,人間のVMAT2の構造を3つの異なる機能状態で決定した.
- レザーピンとケタンセリンは,異なるVMAT2構造を安定させ,基質結合ポケットに結合することが示された.
- テトラベナジンは独特のポケットを結合し,VMAT2を遮断状態に閉じ込め,輸送サイクルの構造的基盤を明らかにしました.
結論:
- 決定された構造は,VMAT2基質の認識,輸送,および薬物抑制のメカニズム的理解を提供します.
- これらの発見は,VMAT2の薬理学を理解するための構造的基盤を提供します.
- この研究は,神経学的および精神的障害に対するVMAT2を標的とした新しい治療薬の合理的な設計を容易にする.
さらに関連する動画
06:18Brain Slice Biotinylation: An Ex Vivo Approach to Measure Region-specific Plasma Membrane Protein Trafficking in Adult Neurons
Published on: April 3, 2014
13.0K
09:12Selection of Transporter-Targeted Inhibitory Nanobodies by Solid-Supported-Membrane SSM-Based Electrophysiology
Published on: May 3, 2021
2.6K
関連する概念動画
01:14Active Transport
722
Active transport is a critical biological process that allows cells to move solutes against an electrochemical gradient. This process requires direct energy input and is characterized by its selectivity, saturability, and susceptibility to competitive inhibition.
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
Primary active transporters, like Na+, K+ and -ATPase, directly utilize ATP to move ions across the membrane. These transporters play significant roles in various physiological processes. For instance, Na+, K+ and -ATPase maintain...
722
01:06Carrier-Mediated Transport
441
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
441
01:44The Significance of Membrane Transport
26.7K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
26.7K
01:32Secondary Active Transport
7.1K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
7.1K
01:19Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
3.8K
Certain large, lipid-insoluble drug molecules that resemble amino acids, peptides, or glucose, require specialized carrier proteins to facilitate their diffusion across cell membranes. This transport can occur through either facilitated diffusion, which does not require energy input, or active transport, which does require energy input.
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
3.8K
01:31Membrane Transporters
11.2K
Transporters are essential membrane transport proteins with functions related to cell nutrition, homeostasis, communication, etc. Approximately 7% of all genes in the human genome code for transporters or transporter-related proteins.
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
Transporters are mainly composed of alpha-helices, built from bundles of ten or more helices traversing the plasma membrane. The solute-binding sites are located midway, where some of the helices are broken or distorted, making space for the binding site through...
11.2K